0.49
-0.0503(-9.23%)
Currency In USD
| Previous Close | 0.54 |
| Open | 0.53 |
| Day High | 0.53 |
| Day Low | 0.49 |
| 52-Week High | 9.36 |
| 52-Week Low | 0.38 |
| Volume | 226,959 |
| Average Volume | 397,652 |
| Market Cap | 45.75M |
| PE | -0.43 |
| EPS | -1.14 |
| Moving Average 50 Days | 0.51 |
| Moving Average 200 Days | 1.04 |
| Change | -0.05 |
If you invested $1000 in Verrica Pharmaceuticals Inc. (VRCA) since IPO date, it would be worth $28.26 as of June 01, 2025 at a share price of $0.495. Whereas If you bought $1000 worth of Verrica Pharmaceuticals Inc. (VRCA) shares 5 years ago, it would be worth $43.01 as of June 01, 2025 at a share price of $0.495.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
WEST CHESTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announc
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
WEST CHESTER, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announc
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
GlobeNewswire Inc.
Apr 30, 2025 12:00 PM GMT
WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today annou